Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide

Alberto Dalla Volta; Francesca Valcamonico; Andrea Zivi; Giuseppe Procopio; Pierangela Sepe; Gianluca Del Conte; Nunzia Di Meo; Silvia Foti; Stefania Zamboni; Caterina Messina; Eleonora Lucchini; Anna Rizzi; Marco Ravanelli; Stefano Calza; Francesca Zacchi; Giovannino Ciccone; Nazareno Suardi; Roberto Maroldi; Davide Farina; Alfredo Berruti

doi:10.1016/j.eururo.2024.05.004

Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide

Eur Urol. 2024 Sep;86(3):268-271. doi: 10.1016/j.eururo.2024.05.004. Epub 2024 May 20.

Authors

Alberto Dalla Volta¹, Francesca Valcamonico², Andrea Zivi³, Giuseppe Procopio⁴, Pierangela Sepe⁴, Gianluca Del Conte⁵, Nunzia Di Meo⁶, Silvia Foti⁵, Stefania Zamboni⁷, Caterina Messina⁸, Eleonora Lucchini⁹, Anna Rizzi¹⁰, Marco Ravanelli⁶, Stefano Calza¹¹, Francesca Zacchi³, Giovannino Ciccone¹², Nazareno Suardi⁷, Roberto Maroldi⁶, Davide Farina⁶, Alfredo Berruti²

Affiliations

¹ Unit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy. Electronic address: [email protected].
² Unit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
³ Division of Oncology, Verona University and Hospital Trust, Verona, Italy; Oncology Area, Section of Innovation Biomedicine, Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.
⁴ Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
⁵ Department of Oncology, Fondazione IRCCS San Raffaele Hospital, Milan, Italy.
⁶ Unit of Radiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
⁷ Unit of Urology, Department of Medical and Surgical Specialties, Radiological Science and Public Health, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
⁸ Unit of Medical Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy.
⁹ Unit of Medical Oncology, ASST Garda, Desenzano, Italy.
¹⁰ Unit of Medical Oncology, ASST Garda, Manerbio, Italy.
¹¹ Unit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
¹² Unit of Clinical Epidemiology, AOU Città della Salute e della Scienza di Torino and CPO Piemonte, Turin, Italy.

PMID: 38772788
DOI: 10.1016/j.eururo.2024.05.004

No abstract available

Publication types

Letter

MeSH terms

Aged
Antineoplastic Agents / therapeutic use
Benzamides*
Bone Neoplasms* / diagnostic imaging
Bone Neoplasms* / drug therapy
Bone Neoplasms* / secondary
Diffusion Magnetic Resonance Imaging*
Humans
Male
Nitriles* / therapeutic use
Phenylthiohydantoin* / analogs & derivatives
Phenylthiohydantoin* / therapeutic use
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / drug therapy
Prostatic Neoplasms* / pathology
Whole Body Imaging

Substances

Nitriles
Phenylthiohydantoin
enzalutamide
Benzamides
Antineoplastic Agents